ArticleBMC cancer2021

EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.

Shunsuke Okamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.